The rs1447295 and DG8S737 markers on chromosome 8q24 and cancer risk in the Polish population

European Journal of Cancer Prevention

Volumn 19, Issue 2, 2010, Pages 167-171

  Wokołorczyk, Dominika ^a   Gliniewicz, Bartomiej ^a   Stojewski, Marcin ^a   Sikorski, Andrzej ^a   Złowocka, Elibieta ^a   Dȩbniak, Tadeusz ^a   Jakubowska, Anna ^a   Górski, Bohdan ^a   Van De Wetering, Thierry ^a   Narod, Steven A ^b   Lubiński, Jan ^a   Cybulski, Cezary ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b Centre for Research on Women's Health   (Canada)

Author keywords

Chromosome 8q24; DG8S737; Hereditary; Prostate cancer; Rs1447295

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RISK; CHROMOSOME 8Q; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILIAL CANCER; FEMALE; GENE FREQUENCY; GENOTYPE; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLAND; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 8; DNA, NEOPLASM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; POLAND; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; YOUNG ADULT;

EID: 76449083552     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32832945c3     Document Type: Article

References (33)

1. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, et al. (2006). A common variant associated with prostate cancer in European and African populations. Nat Genet 38:652-658.
2. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, et al. (1996). Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 56:3091-3102.
3. Cybulski C, Gorski B, Debniak T, Gliniewicz B, Mierzejewski M, Masojć B, et al. (2004a). NBS1 is a prostate cancer susceptibility gene. Cancer Res 64:1215-1219. (Pubitemid 38235583)
4. Cybulski C, Huzarski T, Gorski B, Masojć B, Mierzejewski M, Debniak T, et al. (2004b). A novel founder CHEK2 mutation is associated with increased prostate cancer risk. Cancer Res 64:2677-2679.
5. Dong X, Wang L, Taniguchi K, Wang X, Cunningham JM, McDonnell SK, et al. (2003). Mutations in CHEK2 associated with prostate cancer risk. Am J Hum Genet 72:270-280. (Pubitemid 36194238)
6. Edwards SM, Kote-Jarai Z, Meitz J, Hamoudi R, Hope Q, Osin P, et al. (2003). Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet 72:1-12.
7. Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A,Waliszewska A, et al. (2006). Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci U S A 103:14068-14073.
8. Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE, et al. (2008). Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst 100:962-966.
9. Giusti RM, Rutter JL, Duray PH, Freedman LS, Konichezky M, Fisher-Fischbein J, et al. (2003). A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J Med Genet 40:787-792.
10. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, Helgason A (2007). Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 39: 631-637.
11. Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A, et al. (2007). Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 39:638-644.
12. Isaacs SD, Kiemeney LA, Baffoe-Bonnie A, Beaty TH, Walsh PC (1995). Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst 87:991-996.
13. Kirchhoff T, Kauff ND, Mitra N, Nafa K, Huang H, Palmer C, et al. (2004). BRCA mutations and risk of prostate cancer in Ashkenazi Jews. Clin Cancer Res 10:2918-2921.
14. Nupponen N, Visakorpi T (1999). Molecular biology of progression of prostate cancer. Eur Urol 35:351-354.
15. Platz EA (2007). Genetic variation at 8q24 as a susceptibility factor for prostate cancer: definitive results from epidemiologic studies? Cancer Res 67:2905-2907.
16. Ribeiro FR, Jeronimo C, Henrique R, Fonseca D, Oliveira J, Ragnhild AL, et al. (2006). 8q gain is an independent predictor of poor survival in diagnostic needle biopsies from prostate cancer suspects. Clin Cancer Res 12:3961-3970.
17. Schumacher R, Feigelson H, Cox D, Haiman CA, Albane D, Bering J, et al. (2007). A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res 67:2951-2956.
18. Seppala EH, Ikonen T, Mononen N, Autio V, Rökman A, Matikainen MP, et al. (2003). CHEK2 variants associate with hereditary prostate cancer. Br J Cancer 89:1966-1970.
19. Sigurdsson S, Thorlacius S, Tomasson J, Tryggvadottir L, Benediktsdottir K, Eyfjörd JE, et al. (1997). BRCA2 mutation in Icelandic prostate cancer patients. J Mol Med 75:758-761.
20. Struewing JP, Hartge P, Wacholder S, Baker SA, Berlin M, McAdams M, et al. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401-1408.
21. Suuriniemi M, Agalliu I, Schaid DJ, Johanneson B, McDonnell SK, Iwasaki L, et al. (2007). Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24. Cancer Epidemiol Biomarkers Prev 16:809-814.
22. The Breast Cancer Linkage Consortium (1999). Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91:1310-1316.
23. Tryggvadottir L, Vidarsdottir L, Thorgeirsson T, Jonasson JG, O ́ lafsdó ttir EJ, O ́ lafsdó ttir GH, et al. (2007). Prostate cancer progression and survival in BRCA2 mutation carriers. J Natl Cancer Inst 99:929-935.
24. Tulinius H, Olafsdottir GH, Sigvaldason H, Neuhausen S, Jonasson JG, Tavtigian SV, et al. (2002). The effect of a single BRCA2 mutation on cancer in Iceland. J Med Genet 39:457-462.
25. Van Asperen CJ, Brohet RM, Meijers-Heijboer EJ, Hoogerbrugge N, Verhoef S, Vasen HFA, et al. (2005). Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet 42:711-719.
26. Van Duin M, Van Marion R, Vissers K,Watson JEV, VanWeerdenWM, Schröder FH, et al. (2005). High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer. Genes Chromosomes Cancer 44:438-449.
27. Verhage BA, Aben KK, Witjes JA, Straatman H, Schalken JA, Kiemeney LA. (2004). Site-specific familial aggregation of prostate cancer. Int J Cancer 109:611-617.
28. Wang L, McDonnell S, Slusser J, Hebbring SJ, Cunningham JM, Jacobsen SJ, et al. (2007). Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. Cancer Res 67:2944-2950.
29. Witte JS (2007). Multiple prostate cancer risk variants on 8q24. Nat Genet 39:579-580.
30. Wokolorczyk D, Gliniewicz B, Sikorski A, Zlowocka E, Masojć B, Debniak T, et al. (2008). A range of cancers is associated with the rs6983267 marker on chromosome 8. Cancer Res 68:9982-9986.
31. Wokolorczyk D, Lubiñ ski J, Narod SA, Cybulski A. Genetic heterogeneity of 8q24 region in susceptibility to cancer. J Natl Cancer Inst (in press).
32. Xu J, Dimitrov L, Chang BL, Adams T, Turner A, Meyers D, et al. (2005). A combined genomewide linkage scan of 1233 families for prostate cancersusceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet 77:219-229.
33. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, et al. (2007). Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39:645-649.